Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 188

Similar articles for PubMed (Select 16988585)

1.

Molecular changes in brain tumors: prognostic and therapeutic impact.

Sanson M, Laigle-Donadey F, Benouaich-Amiel A.

Curr Opin Oncol. 2006 Nov;18(6):623-30. Review.

PMID:
16988585
2.

Molecular genetic markers as predictors of response to chemotherapy in gliomas.

Idbaih A, Omuro A, Ducray F, Hoang-Xuan K.

Curr Opin Oncol. 2007 Nov;19(6):606-11. Review.

PMID:
17906460
3.

Gliomas: advances in molecular analysis and characterization.

Boudreau CR, Yang I, Liau LM.

Surg Neurol. 2005 Oct;64(4):286-94; discussion 294. Review.

PMID:
16229087
4.

Neuropathological and molecular aspects of low-grade and high-grade gliomas.

Michotte A, Neyns B, Chaskis C, Sadones J, In 't Veld P.

Acta Neurol Belg. 2004 Dec;104(4):148-53. Review.

PMID:
15742604
5.

[Update on the molecular biology of gliomas: towards a pathomolecular classification of gliomas].

Idoate MA, Echeveste J.

Rev Neurol. 2007 Feb 16-28;44(4):217-24. Review. Spanish.

6.

New frontiers in the treatment of malignant glioma.

Macdonald DR.

Semin Oncol. 2003 Dec;30(6 Suppl 19):72-6. Review.

PMID:
14765391
7.

Molecular diagnostics of gliomas: the clinical perspective.

Tabatabai G, Stupp R, van den Bent MJ, Hegi ME, Tonn JC, Wick W, Weller M.

Acta Neuropathol. 2010 Nov;120(5):585-92. doi: 10.1007/s00401-010-0750-6. Epub 2010 Sep 23. Review.

PMID:
20862485
8.

State of the science in brain tumor classification.

Doolittle ND.

Semin Oncol Nurs. 2004 Nov;20(4):224-30. Review.

PMID:
15612598
9.

Beyond grade: molecular pathology of malignant gliomas.

Sulman EP, Guerrero M, Aldape K.

Semin Radiat Oncol. 2009 Jul;19(3):142-9. doi: 10.1016/j.semradonc.2009.02.001.

PMID:
19464628
10.

[Molecular diagnostic testing in gliomas].

Hasselblatt M.

Pathologe. 2008 Nov;29(6):422-7. doi: 10.1007/s00292-008-1060-9. German.

PMID:
18779965
11.

[Histological and molecular classification of gliomas].

Figarella-Branger D, Colin C, Coulibaly B, Quilichini B, Maues De Paula A, Fernandez C, Bouvier C.

Rev Neurol (Paris). 2008 Jun-Jul;164(6-7):505-15. doi: 10.1016/j.neurol.2008.03.011. Epub 2008 Jun 10. Review. French.

PMID:
18565348
12.

Shared molecular targets in pediatric gliomas and ependymomas.

Tsuruta T, Aihara Y, Kanno H, Funase M, Murayama T, Osawa M, Fujii H, Kubo O, Okada Y.

Pediatr Blood Cancer. 2011 Dec 15;57(7):1117-23. doi: 10.1002/pbc.23009. Epub 2011 Feb 4.

PMID:
21298772
13.

Pathological classification of brain tumors.

Pollo B.

Q J Nucl Med Mol Imaging. 2012 Apr;56(2):103-11. Review.

PMID:
22617234
14.

Molecular markers in gliomas: impact for the clinician.

Hofer S, Lassman AB.

Target Oncol. 2010 Sep;5(3):201-10. doi: 10.1007/s11523-010-0157-2. Epub 2010 Aug 31. Review.

PMID:
20809335
15.

Molecular changes in gliomas.

Sanson M, Thillet J, Hoang-Xuan K.

Curr Opin Oncol. 2004 Nov;16(6):607-13. Review.

PMID:
15627025
16.

[Prognostic and predictive factors for gliomas in adults].

Frenel JS, Botti M, Loussouarn D, Campone M.

Bull Cancer. 2009 Apr;96(4):357-67. doi: 10.1684/bdc.2008.0776. Review. French.

PMID:
19357011
17.

Genetics of medulloblastoma: clues for novel therapies.

Onvani S, Etame AB, Smith CA, Rutka JT.

Expert Rev Neurother. 2010 May;10(5):811-23. doi: 10.1586/ern.10.31. Review.

PMID:
20420498
18.

Molecular advances of brain tumors in radiation oncology.

Noda SE, El-Jawahri A, Patel D, Lautenschlaeger T, Siedow M, Chakravarti A.

Semin Radiat Oncol. 2009 Jul;19(3):171-8. doi: 10.1016/j.semradonc.2009.02.005. Review.

PMID:
19464632
19.

Diagnostic and prognostic molecular markers in common adult gliomas.

Rivera AL, Pelloski CE.

Expert Rev Mol Diagn. 2010 Jul;10(5):637-49. doi: 10.1586/erm.10.44.

PMID:
20629512
20.

Current concepts in the pathology and genetics of gliomas.

Sarkar C, Jain A, Suri V.

Indian J Cancer. 2009 Apr-Jun;46(2):108-19. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk